Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers

BACKGROUND: HER2 mutation has been found to be an oncogenic driver gene in non-small cell lung cancers(NSCLC) and HER2-directed therapies have shown promising results in this unique population, while little is known about its association with outcomes of chemotherapy. The aim of this study was to in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Wang, Yan, Zhang, Shijia, Wu, Fengying, Zhao, Jing, Li, Xuefei, Zhao, Chao, Ren, Shengxiang, Zhou, Caicun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5869778/
https://ncbi.nlm.nih.gov/pubmed/29587667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4277-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados